1
Organizational Change and Research
Vicki Goodman
Collage of Health and Human Sciences
Northern Kentucky University
MSN 602: Advanced Theoretical Foundations of Nursing Practice
09/24/2023
, 2
Organizational Change and Research
Slide 2 – Introduction
Attention deficit disorder is significantly associated with depression. Research evidence
has indicated the incidence of depressive behaviors in individuals with attention depressive
disorder (ADD), suggesting co-occurrence of depression with attention deficit disorder patients
(Demontis et al., 2019). Riglin et al. (2021) found that the recurrence rate of depression is higher
in ADD patients than in patients without ADD – 32.7% and 26.5%, respectively. Depression
treatments have significantly improved in recent decades, but the prevalence rate of depression
remains high (Ormel et al., 2022). Pharmacological therapies, mainly antidepressants, are well-
recognized therapies for depression; however, it is commonly associated with significant side
effects and adverse events, including functional impairment, suicide ideation, self-injury, suicide
attempts, low quality of life, and high recurrence and relapse rates that impair successful
treatment outcomes (Al-Harbi et al., 2012; Braund et al., 2021). Nevertheless, research evidence,
including randomized controlled trials, has indicated the superiority of therapy sessions or non-
pharmacological, including psychotherapy and cognitive behavioral therapy, to pharmacological
therapy in treating major depression disorder and preventing relapse (Cuijpers et al., 2023;
Siddique et al., 2012). Furthermore, research evidence has shown that incorporating therapy
sessions with medications is more efficacious or superior to medication or a therapy session
alone in treating depression (Cuijpers et al., 2014; Cuijpers et al., 2019; Cuijpers et al., 2021;
Kamenov et al., 2017). Hence, there is a need for a change – implementing combined therapy
session with medications to reduce the incidence of depression in ADD patients.
Organizational Change and Research
Vicki Goodman
Collage of Health and Human Sciences
Northern Kentucky University
MSN 602: Advanced Theoretical Foundations of Nursing Practice
09/24/2023
, 2
Organizational Change and Research
Slide 2 – Introduction
Attention deficit disorder is significantly associated with depression. Research evidence
has indicated the incidence of depressive behaviors in individuals with attention depressive
disorder (ADD), suggesting co-occurrence of depression with attention deficit disorder patients
(Demontis et al., 2019). Riglin et al. (2021) found that the recurrence rate of depression is higher
in ADD patients than in patients without ADD – 32.7% and 26.5%, respectively. Depression
treatments have significantly improved in recent decades, but the prevalence rate of depression
remains high (Ormel et al., 2022). Pharmacological therapies, mainly antidepressants, are well-
recognized therapies for depression; however, it is commonly associated with significant side
effects and adverse events, including functional impairment, suicide ideation, self-injury, suicide
attempts, low quality of life, and high recurrence and relapse rates that impair successful
treatment outcomes (Al-Harbi et al., 2012; Braund et al., 2021). Nevertheless, research evidence,
including randomized controlled trials, has indicated the superiority of therapy sessions or non-
pharmacological, including psychotherapy and cognitive behavioral therapy, to pharmacological
therapy in treating major depression disorder and preventing relapse (Cuijpers et al., 2023;
Siddique et al., 2012). Furthermore, research evidence has shown that incorporating therapy
sessions with medications is more efficacious or superior to medication or a therapy session
alone in treating depression (Cuijpers et al., 2014; Cuijpers et al., 2019; Cuijpers et al., 2021;
Kamenov et al., 2017). Hence, there is a need for a change – implementing combined therapy
session with medications to reduce the incidence of depression in ADD patients.
